Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hinge Health (HNGE) Research & Development (2024 - 2025)

Hinge Health (HNGE) has disclosed Research & Development for 2 consecutive years, with $32.8 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 46.42% to $32.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $367.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $368.1 million for FY2025, 265.07% up from the prior year.
  • Research & Development hit $32.8 million in Q4 2025 for Hinge Health, up from $31.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $280.0 million in Q2 2025 to a low of $22.4 million in Q4 2024.